Italy
· Delayed Price · Currency is EUR Philogen Statistics
Total Valuation
Philogen has a market cap or net worth of EUR 882.34 million. The enterprise value is 831.65 million.
| Market Cap | 882.34M |
| Enterprise Value | 831.65M |
Important Dates
The last earnings date was Tuesday, May 6, 2025.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Philogen has 40.29 million shares outstanding.
| Current Share Class | 28.92M |
| Shares Outstanding | 40.29M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 4.54% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 19.48 and the forward PE ratio is 10.05.
| PE Ratio | 19.48 |
| Forward PE | 10.05 |
| PS Ratio | 11.36 |
| PB Ratio | 6.36 |
| P/TBV Ratio | 6.42 |
| P/FCF Ratio | 22.81 |
| P/OCF Ratio | 21.60 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.98, with an EV/FCF ratio of 21.50.
| EV / Earnings | 18.36 |
| EV / Sales | 10.71 |
| EV / EBITDA | 19.98 |
| EV / EBIT | 22.04 |
| EV / FCF | 21.50 |
Financial Position
The company has a current ratio of 1.19
| Current Ratio | 1.19 |
| Quick Ratio | 0.92 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 11.48 |
Financial Efficiency
Return on equity (ROE) is 39.51% and return on invested capital (ROIC) is 19.32%.
| Return on Equity (ROE) | 39.51% |
| Return on Assets (ROA) | 17.08% |
| Return on Invested Capital (ROIC) | 19.32% |
| Return on Capital Employed (ROCE) | 26.70% |
| Revenue Per Employee | 446,282 |
| Profits Per Employee | 260,299 |
| Employee Count | 165 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 13.08 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +21.67% in the last 52 weeks. The beta is 0.15, so Philogen's price volatility has been lower than the market average.
| Beta (5Y) | 0.15 |
| 52-Week Price Change | +21.67% |
| 50-Day Moving Average | 20.00 |
| 200-Day Moving Average | 19.81 |
| Relative Strength Index (RSI) | 74.00 |
| Average Volume (20 Days) | 9,334 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Philogen had revenue of EUR 77.65 million and earned 45.29 million in profits.
| Revenue | 77.65M |
| Gross Profit | 41.62M |
| Operating Income | 37.73M |
| Pretax Income | 40.38M |
| Net Income | 45.29M |
| EBITDA | 41.62M |
| EBIT | 37.73M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | n/a |
| Net Cash | n/a |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 138.66M |
| Book Value Per Share | n/a |
| Working Capital | 3.03M |
Cash Flow
In the last 12 months, operating cash flow was 40.84 million and capital expenditures -2.17 million, giving a free cash flow of 38.68 million.
| Operating Cash Flow | 40.84M |
| Capital Expenditures | -2.17M |
| Free Cash Flow | 38.68M |
| FCF Per Share | 0.96 |
Margins
Gross margin is 53.60%, with operating and profit margins of 48.59% and 58.33%.
| Gross Margin | 53.60% |
| Operating Margin | 48.59% |
| Pretax Margin | 52.00% |
| Profit Margin | 58.33% |
| EBITDA Margin | 53.60% |
| EBIT Margin | 48.59% |
| FCF Margin | 49.80% |
Dividends & Yields
Philogen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 5.13% |
| FCF Yield | 4.38% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |